ArticleACS medicinal chemistry letters2011

Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist.

Paul Eastwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.